- Alongside Q1 results, the company says it expects full-year Copiktra sales to be $10M-$12M, far short of estimates in the $40M area.
- VSTM -24.9% after hours
- Previously: Verastem misses by $0.05, misses on revenue (May 9)
Disappointing outlook dooms Verastem
Recommended For You
About VSTM Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
VSTM | - | - |
Verastem, Inc. |